Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion

被引:30
|
作者
Margolis, Elyssa B. [1 ]
Karkhanis, Anushree N. [2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, Alcohol & Addict Res Grp, 675 Nelson Rising Lane,Box 0444, San Francisco, CA 94143 USA
[2] SUNY Binghamton, Dept Psychol, Dev Exposure Alcohol Res Ctr, Ctr Dev & Behav Neurosci, 4400 Vestal Pkwy East, Binghamton, NY 13902 USA
基金
美国国家卫生研究院;
关键词
VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS SHELL; PLACE PREFERENCE PARADIGM; SOCIAL DEFEAT STRESS; SELECTIVE ACTIVATION; CATECHOLAMINE INNERVATION; PRESYNAPTIC INHIBITION; BASOLATERAL AMYGDALA; LATERAL HABENULA; MEASURING REWARD;
D O I
10.1016/j.neuint.2019.104504
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neural circuits that enable an organism to protect itself by promoting escape from immediate threat and avoidance of future injury are conceptualized to carry an "aversive" signal. One of the key molecular elements of these circuits is the kappa opioid receptor (KOR) and its endogenous peptide agonist, dynorphin. In many cases, the aversive response to an experimental manipulation can be eliminated by selective blockade of KOR function, indicating its necessity in transmitting this signal. The dopamine system, through its contributions to reinforcement learning, is also involved in processing of aversive stimuli, and KOR control of dopamine in the context of aversive behavioral states has been intensely studied. In this review, we have discussed the multiple ways in which the KORs regulate dopamine dynamics with a central focus on dopamine neurons and projections from the ventral tegmental area. At the neuronal level, KOR agonists inhibit dopamine neurons both in the somatodendritic region as well as at terminal release sites, through various signaling pathways and ion channels, and these effects are specific to different synaptic sites. While the dominant hypotheses are that aversive states are driven by decreases in dopamine and increases in dynorphin, reported exceptions to these patterns indicate these ideas require refinement. This is critical given that KOR is being considered as a target for development of new therapeutics for anxiety, depression, pain, and other psychiatric disorders.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Kappa Opioid Receptors on Dopaminergic Neurons Are Necessary for Kappa-Mediated Place Aversion
    Vladimir I Chefer
    Cristina M Bäckman
    Eduardo D Gigante
    Toni S Shippenberg
    Neuropsychopharmacology, 2013, 38 : 2623 - 2631
  • [2] Kappa Opioid Receptors on Dopaminergic Neurons Are Necessary for Kappa-Mediated Place Aversion
    Chefer, Vladimir I.
    Baeckman, Cristina M.
    Gigante, Eduardo D.
    Shippenberg, Toni S.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (13) : 2623 - 2631
  • [3] Circuit and Cellular Mechanisms of Prefrontocortical Kappa Opioid Receptor-Mediated Disruptions in Working Memory
    Abraham, Antony
    Casello, Sanne
    Rivera, Zeena
    Andrews, Mackenzie
    Land, Benjamin
    Chavkin, Charles
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 184 - 185
  • [4] Does the kappa opioid receptor system contribute to pain aversion?
    Cahill, Catherine M.
    Taylor, Anna M. W.
    Cook, Christopher
    Ong, Edmund
    Moron, Jose A.
    Evans, Christopher J.
    FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [5] SEXUAL DIFFERENCES IN KAPPA OPIOID RECEPTOR-MEDIATED REGULATION OF TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS
    MANZANARES, J
    WAGNER, EJ
    LAVIGNE, SD
    LOOKINGLAND, KJ
    MOORE, KE
    NEUROENDOCRINOLOGY, 1992, 55 (03) : 301 - 307
  • [6] KAPPA-OPIOID RECEPTOR-MEDIATED REGULATION OF DOPAMINERGIC-NEURONS IN THE RAT-BRAIN
    MANZANARES, J
    LOOKINGLAND, KJ
    MOORE, KE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 256 (02): : 500 - 505
  • [7] A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist
    Ackley, MA
    Hurley, RW
    Virnich, DE
    Hammond, DL
    PAIN, 2001, 91 (03) : 377 - 388
  • [8] Probing the Cellular Basis of Spinal Kappa Opioid Receptor Inhibition of Itch
    Sheahan, Tayler D.
    Manalo, Allison P.
    Perry, Vijay J.
    Fanien, Louis G.
    Warwick, Charles A.
    Smith, Kelly M.
    Ross, Sarah E.
    JOURNAL OF PAIN, 2022, 23 (05): : 9 - 9
  • [9] Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion
    Hugo A Tejeda
    Danielle S Counotte
    Eric Oh
    Sammanda Ramamoorthy
    Kristin N Schultz-Kuszak
    Cristina M Bäckman
    Vladmir Chefer
    Patricio O'Donnell
    Toni S Shippenberg
    Neuropsychopharmacology, 2013, 38 : 1770 - 1779
  • [10] Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion
    Tejeda, Hugo A.
    Counotte, Danielle S.
    Oh, Eric
    Ramamoorthy, Sammanda
    Schultz-Kuszak, Kristin N.
    Baeckman, Cristina M.
    Chefer, Vladmir
    O'Donnell, Patricio
    Shippenberg, Toni S.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (09) : 1770 - 1779